The therapeutic candidates discussed on this site are investigational biological compounds currently undergoing preclinical and clinical evaluations. They have not received marketing authorization, clearance, or approval from the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any other regulatory health authority. Safety, efficacy, and clinical endpoints remain under active investigation. Nothing on this website constitutes medical advice or an offering of securities.